BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32029385)

  • 1. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in Kayseri, Turkey.
    Atayoglu AT; Inanc N; Başmisirli E; Çapar AG
    Prim Care Diabetes; 2020 Oct; 14(5):488-493. PubMed ID: 32029385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the Finnish Diabetes Risk Score (FINDRISC) and Modified Asian FINDRISC (ModAsian FINDRISC) for screening of undiagnosed type 2 diabetes mellitus and dysglycaemia in primary care.
    Lim HM; Chia YC; Koay ZL
    Prim Care Diabetes; 2020 Oct; 14(5):494-500. PubMed ID: 32156516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neck Circumference and its Correlation to Other Anthropometric Parameters and Finnish Diabetes Risk Score (FINDRISC).
    Volaco A; Martins CM; Soares JQ; Cavalcanti AM; Moyses ST; Filho RP; Baena CP; Precoma DB
    Curr Diabetes Rev; 2018; 14(5):464-471. PubMed ID: 28969558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining type 2 diabetes risk factors for the adults: A community based study from Turkey.
    Cosansu G; Celik S; Özcan S; Olgun N; Yıldırım N; Gulyuz Demir H
    Prim Care Diabetes; 2018 Oct; 12(5):409-415. PubMed ID: 29804712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the Finnish Diabetes Risk Score (FINDRISC), vitamin D levels, and insulin resistance in obese subjects.
    Lima-Martínez MM; Arrau C; Jerez S; Paoli M; González-Rivas JP; Nieto-Martínez R; Iacobellis G
    Prim Care Diabetes; 2017 Feb; 11(1):94-100. PubMed ID: 27914905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort.
    Silvestre MP; Jiang Y; Volkova K; Chisholm H; Lee W; Poppitt SD
    Prim Care Diabetes; 2017 Dec; 11(6):561-569. PubMed ID: 28801192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the Finnish Diabetes risk Score and the severity of coronary artery disease.
    Djurić P; Mladenović Z; Grdinić A; Tavčiovski D; Spasić M; Davičević-Elez Z
    Vojnosanit Pregl; 2014 May; 71(5):474-80. PubMed ID: 26137713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epicardial adipose tissue thickness and type 2 diabetes risk according to the FINDRISC modified for Latin America.
    Lima-Martínez MM; Colmenares L; Campanelli Y; Paoli M; Rodney M; Santos RD; Iacobellis G
    Clin Investig Arterioscler; 2019; 31(1):15-22. PubMed ID: 30166212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FINDRISC Modified for Latin America as a Screening Tool for Persons with Impaired Glucose Metabolism in Ciudad Bolívar, Venezuela.
    Muñoz-González MC; Lima-Martínez MM; Nava A; Trerotola G; Paoli M; Cabrera-Rego JO; Gonzalez B; Arciniegas A; Paez J
    Med Princ Pract; 2019; 28(4):324-332. PubMed ID: 30852570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study.
    Hellgren MI; Petzold M; Björkelund C; Wedel H; Jansson PA; Lindblad U
    Diabet Med; 2012 Dec; 29(12):1501-5. PubMed ID: 22443428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in occupational health care.
    Vandersmissen GJ; Godderis L
    Int J Occup Med Environ Health; 2015; 28(3):587-91. PubMed ID: 26190733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the modified FINDRISC to identify individuals at high risk for diabetes among middle-aged white and black ARIC study participants.
    Kulkarni M; Foraker RE; McNeill AM; Girman C; Golden SH; Rosamond WD; Duncan B; Schmidt MI; Tuomilehto J
    Diabetes Obes Metab; 2017 Sep; 19(9):1260-1266. PubMed ID: 28321981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A more simplified Finnish diabetes risk score for opportunistic screening of undiagnosed type 2 diabetes in a German population with a family history of the metabolic syndrome.
    Li J; Bergmann A; Reimann M; Bornstein SR; Schwarz PE
    Horm Metab Res; 2009 Feb; 41(2):98-103. PubMed ID: 18975253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population.
    Bernabe-Ortiz A; Perel P; Miranda JJ; Smeeth L
    Prim Care Diabetes; 2018 Dec; 12(6):517-525. PubMed ID: 30131300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The performance of the Finnish Diabetes Risk Score, a modified Finnish Diabetes Risk Score and a simplified Finnish Diabetes Risk Score in community-based cross-sectional screening of undiagnosed type 2 diabetes in the Philippines.
    Ku GM; Kegels G
    Prim Care Diabetes; 2013 Dec; 7(4):249-59. PubMed ID: 23953706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External validation of the Finnish diabetes risk score in Venezuela using a national sample: The EVESCAM.
    Nieto-Martínez R; González-Rivas JP; Ugel E; Marulanda MI; Durán M; Mechanick JI; Aschner P
    Prim Care Diabetes; 2019 Dec; 13(6):574-582. PubMed ID: 31202539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
    Salinero-Fort MA; Burgos-Lunar C; Lahoz C; Mostaza JM; Abánades-Herranz JC; Laguna-Cuesta F; Estirado-de Cabo E; García-Iglesias F; González-Alegre T; Fernández-Puntero B; Montesano-Sánchez L; Vicent-López D; Cornejo-Del Río V; Fernández-García PJ; Sánchez-Arroyo V; Sabín-Rodríguez C; López-López S; Patrón-Barandio P; Gómez-Campelo P;
    PLoS One; 2016; 11(7):e0158489. PubMed ID: 27441722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a screening tool using electronic health records for undiagnosed Type 2 diabetes mellitus and impaired fasting glucose detection in the Slovenian population.
    Štiglic G; Kocbek P; Cilar L; Fijačko N; Stožer A; Zaletel J; Sheikh A; Povalej Bržan P
    Diabet Med; 2018 May; 35(5):640-649. PubMed ID: 29460977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using HbA1c measurements and the Finnish Diabetes Risk Score to identify undiagnosed individuals and those at risk of diabetes in primary care.
    Arnardóttir E; Sigurðardóttir ÁK; Graue M; Kolltveit BH; Skinner T
    BMC Public Health; 2023 Jan; 23(1):211. PubMed ID: 36721135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for people with abnormal glucose metabolism in the European DE-PLAN project.
    Cos FX; Barengo NC; Costa B; Mundet-Tudurí X; Lindström J; Tuomilehto JO;
    Diabetes Res Clin Pract; 2015 Jul; 109(1):149-56. PubMed ID: 25931281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.